Acorn Regulatory

The Regulatory Affairs Experts

  • Our Services
    • Product Registrations & Maintenance
    • Pharmacovigilance Services
    • Veterinary Regulatory Affairs
    • eCTD & Electronic Publishing Services
    • QMS & GDP/GMP Services
      • Wholesale Distribution Authorisation
    • Advertising Compliance Review
    • Medical Device Services
    • EU Authorised Representative
    • Clinical Trials Services
    • Clinical Evaluation Report (CER) Writing
    • Resourcing & Outsourcing
  • Who We Are
    • About Us
    • Testimonials
    • Memberships & Accreditation
    • Work With Us
  • News
    • Acorn Regulatory News
    • Pharmaceutical
    • Medical Devices
    • Pharmacovigilance
    • eCTD & Electronic Publishing
    • Quality Management System
    • Clinical Trials
    • Industry News
    • Brexit
    • Publications
  • Careers
    • Our Business – Where Do You Fit In?
    • Who We Are
    • Latest Regulatory Affairs Vacancies
    • Regulatory Affairs Careers Blog
    • Recruitment Agencies
  • Contact Us
    • Privacy Policy
    • Cookie Policy
Home » Most Read Acorn Regulatory Pharmaceutical Articles of 2017

December 11, 2017 by Acornreg2017

Most Read Acorn Regulatory Pharmaceutical Articles of 2017

Over the course of the past twelve months the Acorn Regulatory pharmaceutical division has worked on projects in more than 70 countries around the world.  In that time they have also taken time out to write some very well received articles that have been read thousands of times.  These are the 5 most read articles in 2017 from the Acorn Regulatory pharmaceutical team. 

Are You Ready for the Falsified Medicines Directive?

The Falsified Medicines Directive was published in 2011 with the aim of preventing falsified medicines from entering the pharmaceutical supply chain in the European Economic Area.

The falsification of medicines has long been a problem.  In recent years the issue has escalated despite the best efforts of agencies such as Medi-Fake.  As such, there has been a need to introduce a stronger legislative framework to combat the growth of the problem.  The Falsified Medicines Directive (FMD) has been in place since 2013 and companies have been required to implement aspects of the directive since then.  Complete conformity with the Falsified Medicines Directive will be required from February 9th 2019. Read more here.

5 Steps To Obtain A Wholesale Distribution Authorisation Licence

The WDA process is complex.  Indeed, many companies turn to us to manage the application process on their behalf. Here, we have highlighted 5 steps that companies must undertake if they want to secure a Wholesale Distribution Authorisation licence. Read more here.

Virtual Wholesaling of Medicinal Products: 5 Things You Need To Know

In this article we look at the five things that you need to know when considering virtual wholesaling. Read more here.

Pharmaceutical Code of Practice – Are You Aware of Your Responsibilities?

In this article we look at the issues surrounding the code of practice that governs pharmaceutical companies in the UK or Ireland.  The IPHA and ABPI codes cover the promotion of medicines for prescribing to both health professionals and other relevant decision makers. Read more here.

An Overview of Medicinal Product Labelling

Every day we are presented with many different types of labels; from the laundry instructions included on clothing labels to nutritional information on food and drink packaging, labels are all around us. So what do these different types of label have in common?  They all aim to provide us with information about the associated product. Read more here.

If you would like to talk to us about your regulatory affairs requirements then simply contact us by using the form below or call us on 00353 52 61 76 706.

Share this Acorn Regulatory article

  • LinkedIn
  • Twitter
  • Email
  • More
  • Print
  • Facebook
  • Pocket

Related

Filed Under: Acorn Regulatory News

Quick Links

About Us

Pharmaceutical Sector Services

Medical Device Sector Services

Pharmacovigilance Services

Clinical Trials Services

EU Authorised Representative

Wholesale Distribution Authorisation

 

Latest News

  • What We Have Learned About Work Flexibility
  • Download ‘Regulatory Intelligence 3’
  • Repeat Use Procedure – An Overview
  • Acorn Regulatory Takes Part in EI Trade Mission to Italy
  • More Featured Articles from the Acorn Regulatory Top 100
  • GDPR & Life Science Companies – 8 Things You Need To Know

Get in touch with us

Acorn Regulatory,
Suite 6, Powerstown House,
Gurtnafleur Business Park,
Clonmel,
Co. Tipperary,
E91 V9P7,
Ireland.
Tel: 00353 52 61 76 706
Fax: 00353 52 61 48 806
E-mail: info@acornregulatory.com

Translate Our Website

©2018 Acorn Regulatory Consultancy Services Ltd. Company Registration No. 397294 VAT Registered No. IE 6417294V

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.

Cookies

This site uses cookies: Find out more.